Enanta Pharmaceuticals ENTA
NASDAQ ENTA
$12.59 -0.25 (-1.95%)
As of: Oct 2, 2026 · 2:16 PM EDT

Enanta Pharmaceuticals (ENTA) Depreciation & Amortization (CF) (2012 - 2026)

Updated

Enanta Pharmaceuticals (ENTA) posted Depreciation & Amortization (CF) of $1.19 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 2.1% from $1.21 million a year earlier and down 2.0% from the prior quarter.

Analysis

Enanta Pharmaceuticals (ENTA) Depreciation & Amortization (CF) (2012 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Depreciation & Amortization (CF) at Enanta Pharmaceuticals was $4.91 million, up 29.8% year-over-year; for FY2025 (ended Sep 30, 2025), it was $4.59 million, up 96.3% from FY2024.

  • Annual Depreciation & Amortization (CF) shows a five-year compound annual growth rate of 4.7% (FY2020 to FY2025).
  • In prior fiscal years, Enanta Pharmaceuticals' Depreciation & Amortization (CF) was $2.34 million in FY2024 (-1.5%), $2.37 million in FY2023 (-20.2%), $2.97 million in FY2022 (-10.8%) and $3.33 million in FY2021 (-8.5%).
  • The fiscal Q3 2026 figure stands as the lowest quarterly Depreciation & Amortization (CF) since fiscal Q1 2025.
  • On a year-over-year basis, Depreciation & Amortization (CF) increased in six of the last eight quarters, with growth averaging 51.5%.
  • The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was fiscal Q4 2025, with growth of 168.1%; the weakest was fiscal Q1 2023, with a decline of 34.5%.
  • According to Business Quant data, Depreciation & Amortization (CF) for the three prior fiscal quarters was $1.21 million (Q2 2026), $1.23 million (Q1 2026) and $1.28 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Enanta Pharmaceuticals 383.80 Mn -344.19 Mn - 1.19 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.19 Mn
Mar 31, 2026 1.21 Mn
Dec 31, 2025 1.23 Mn
Sep 30, 2025 1.28 Mn
Jun 30, 2025 1.21 Mn
Mar 31, 2025 1.20 Mn
Dec 31, 2024 889,000.00
Sep 30, 2024 479,000.00
Jun 30, 2024 594,000.00
Mar 31, 2024 621,000.00
Dec 31, 2023 642,000.00
Sep 30, 2023 669,000.00
Jun 30, 2023 651,000.00
Mar 31, 2023 540,000.00
Dec 31, 2022 511,000.00
Sep 30, 2022 655,000.00
Jun 30, 2022 716,000.00
Mar 31, 2022 822,000.00
Dec 31, 2021 780,000.00
Sep 30, 2021 806,000.00
API Access

Enanta Pharmaceuticals Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=ENTA&period=max&api_key=YOUR_API_KEY